Lectin-Based Bispecifics Target Cancer’s Sugar Coating
Researchers have developed a breakthrough cancer immunotherapy that targets the sugary coatings unique to cancer cells. This lectin-based approach could enable pan-cancer treatment while avoiding damage to healthy tissue.